Tg Therapeutics (TGTX) Inventory (2023 - 2026)

Tg Therapeutics' Inventory history runs 4 years deep, the most recent figure standing at $129.0 million for Q1 2026.

• In Q1 2026, Inventory fell 18.21% year-over-year to $129.0 million; the TTM figure through Mar 2026 stood at $129.0 million (down 18.21% YoY), while the FY2025 annual figure was $125.6 million, up 13.7% from the prior year.
• Inventory was $129.0 million for Q1 2026 at Tg Therapeutics, up from $125.6 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $157.8 million in Q1 2025 to a low of $27.2 million in Q1 2023.
• Historically, Inventory has averaged $92.3 million across 4 years, with a median of $84.7 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Inventory surged 185.51% in 2024, then retreated 18.21% in 2026.
• A 4-year view of Inventory shows it stood at $39.8 million in 2023, then surged by 177.37% to $110.5 million in 2024, then increased by 13.7% to $125.6 million in 2025, then gained by 2.74% to $129.0 million in 2026.
• The last three Inventory figures came in at $129.0 million (Q1 2026), $125.6 million (Q4 2025), and $147.0 million (Q3 2025), per Business Quant data.